ZNF195 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.1005419625908E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.01949576453353E-11 |
Normal-vs-Stage2 |
1.261580E-03 |
Normal-vs-Stage3 |
9.42729999620084E-08 |
Normal-vs-Stage4 |
1.24599999984376E-07 |
Stage1-vs-Stage2 |
7.835200E-01 |
Stage1-vs-Stage3 |
7.425000E-01 |
Stage1-vs-Stage4 |
5.756800E-01 |
Stage2-vs-Stage3 |
9.391400E-01 |
Stage2-vs-Stage4 |
9.581600E-01 |
Stage3-vs-Stage4 |
8.533600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.01230135385322E-12 |
Normal-vs-AfricanAmerican |
4.243200E-03 |
Normal-vs-Asian |
2.0332999950412E-08 |
Caucasian-vs-AfricanAmerican |
2.584200E-01 |
Caucasian-vs-Asian |
6.511900E-02 |
AfricanAmerican-vs-Asian |
2.819600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.26483326221705E-12 |
Normal-vs-Female |
1.39860012460247E-10 |
Male-vs-Female |
8.715400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.614140E-02 |
Normal-vs-Age(41-60Yrs) |
3.44502204541186E-12 |
Normal-vs-Age(61-80Yrs) |
5.5951998589876E-10 |
Normal-vs-Age(81-100Yrs) |
3.837000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.450800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.478600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.793200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.533200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.524400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.984600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.537900E-02 |
Normal-vs-Grade 2 |
1.09140474435776E-11 |
Normal-vs-Grade 3 |
4.90719687107344E-11 |
Normal-vs-Grade 4 |
3.436000E-04 |
Grade 1-vs-Grade 2 |
1.016000E-01 |
Grade 1-vs-Grade 3 |
3.122200E-01 |
Grade 1-vs-Grade 4 |
7.180800E-01 |
Grade 2-vs-Grade 3 |
6.123000E-01 |
Grade 2-vs-Grade 4 |
1.301590E-01 |
Grade 3-vs-Grade 4 |
2.027600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.64668279012403E-12 |
Normal-vs-ccB subtype |
1.70770000029741E-07 |
ccA subtype-vs-ccB subtype |
3.846100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.22780008382506E-10 |
Normal-vs-N1 |
5.776300E-02 |
N0-vs-N1 |
9.182100E-02 |
|
|